C-reactive protein (CRP) is a common and important biomarker, which is mainly synthesized by the liver. As inflammation intensifies, its concentration in plasma will increase significantly. At that time, CRP acted as an "alarm" to notify the body of a potential pathological condition and initiate a corresponding immune response, making CRP an important indicator for clinical evaluation of inflammatory conditions.
The physiological role of CRP is to bind to phospholipid choline on the surface of dead cells and some bacteria, activating the complement system, thus promoting the phagocytosis of macrophages and clearing apoptotic and necrotic cells.
As early as 1930, Tillett and Francis discovered CRP and named it because it reacted with the C-polysaccharide of pneumococci in the serum of patients with acute inflammation. It was not clear at the time whether CRP was a pathological secretion, but later studies showed that CRP is a protein naturally synthesized in the liver and is part of the body's natural defense response to infection and inflammation.
CRP belongs to the small galactosin family and consists of 224 amino acids, forming a stable oligomer with a disk-shaped appearance. This structure allows CRP to effectively bind to microorganisms and damaged cells, promoting subsequent immune responses. Most of its functions occur after the formation of its characteristic structural morphology, which is why its effectiveness in treating inflammation and infection is based on it.
In healthy adults, the normal concentration of CRP is between 0.8 mg/L and 3.0 mg/L, but in some cases, CRP levels higher than 10 mg/L may occur even in healthy individuals.
The main function of CRP is to promote the activation of the complement system by binding to pathogens and necrotic cells, and accelerate their phagocytosis by macrophages. This mechanism emphasizes the critical position of CRP in the innate immune system. Recent studies have shown that high levels of CRP are closely related to a variety of chronic diseases, such as cardiovascular disease and diabetes.
The serum concentration of C-reactive protein will change with the degree of infection and inflammation, usually rising significantly within 6 hours and reaching a peak within 48 hours. In cases of acute inflammation, its concentration can even be increased to more than 500 mg/L, allowing medical personnel to use this value as an indicator to monitor disease progression or response to treatment.
When the body faces acute inflammation or infection, CRP concentrations can rise sharply within hours, a property that makes it an effective tool for diagnosis and monitoring.
Diagnostic use: CRP is an important inflammatory marker that can help doctors quickly determine whether patients have inflammation or guide treatment decisions. CRP measurement can be obtained through traditional blood analysis methods, and compared with other indicators such as erythrocyte sedimentation rate (ESR), CRP has higher sensitivity in rapid response.
High-sensitivity C-reactive protein (hs-CRP) testing can detect a lower range of CRP concentrations and further assess cardiovascular disease risk. Research shows that hs-CRP concentrations above 3 mg/L can be considered high risk, while below 1 mg/L indicates lower risk. However, high levels of CRP do not indicate definite cardiovascular disease, so it should be analyzed in conjunction with other risk factors.
The role of CRP is not limited to inflammation indicators. Recent studies have also explored its possible role in cancer, metabolic diseases and other pathological conditions. Although there is some evidence that inflammation may promote the development of certain cancers, the link between CRP and cancer still needs further research to elucidate.
With the advancement of science and technology, research on CRP will likely reveal more of its potential functions in health and disease and provide new targets for diagnosis and treatment. Notably, as our understanding of CRP's properties and functions increases, we need to reassess its role in predicting disease risk and consider its application in personalized medicine.
How will CRP research impact our understanding of inflammation and disease risk in the future?